Quick Takeaways
- EcoR1 Capital, LLC filed SCHEDULE 13G/A for Kura Oncology, Inc. Common Stock (KURA).
- Disclosed ownership: 4.8%.
- Date of event: 30 Jun 2025.
EcoR1 Capital, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Kura Oncology, Inc. Common Stock (KURA)
- Filing Manager
- EcoR1 Capital, LLC
- Reporting Manager
- EcoR1 Capital, LLC
- Security
- Kura Oncology, Inc. Common Stock
- Symbol
- KURA
- Shares outstanding
- 87,500,000 shares
- Disclosed Ownership
- 4,200,000 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 13:26:10 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"EcoR1 Capital, LLC disclosed 4.8% ownership in Kura Oncology, Inc. Common Stock (KURA) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 13:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 4.8% | 4,200,000 | 0 | 4,200,000 | /s/ Oleg Nodelman | Manager | |
| Oleg Nodelman | 4.8% | 4,200,000 | 0 | 4,200,000 | /s/ Oleg Nodelman | Reporting person | |
| EcoR1 Capital Fund Qualified, L.P. | 4.5% | 3,937,232 | 0 | 3,937,232 | /s/ Oleg Nodelman | Manager of the General Partner, EcoR1 Capital, LLC |